Alkem Laboratories has dispatched letters providing the web-link and exact path to access its Annual Report for the financial year 2025-26 (FY25-26). The communication was sent to shareholders who had not registered their email addresses with the company, its depository participants, or its Registrar to an Issue & Share Transfer Agent (RTA), MUFG Intime India Private Limited, as of the cut-off date on July 10, 2026. This disclosure ensures that all stakeholders can access critical financial information despite the absence of digital contact details.

The intimation was filed with the Bombay Stock Exchange and the National Stock Exchange of India Limited on July 30, 2026, in compliance with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Annual Report is also available on the company’s website at www.alkemlabs.com , under the investors section. Shareholders are encouraged to update their email addresses through their depository participants or by communicating directly with the RTA to facilitate future electronic communications and support the company’s green initiative.

AGM and Dividend Details

The Annual Report pertains to the period leading up to the company’s 52nd Annual General Meeting (AGM), scheduled for August 27, 2026, at 11:00 AM IST. The meeting will be conducted via Video Conferencing or Other Audio Visual Means. Shareholders holding shares as of the record date, August 20, 2026, are eligible to vote. Remote e-voting will be open from August 24 to August 26, 2026.

Additionally, the company has fixed August 7, 2026, as the record date for determining dividend entitlements for FY25-26. If approved by members during the AGM, the final dividend will be paid on or after September 1, 2026. Investors are advised to submit necessary documents for Tax Deducted at Source (TDS) compliance under the Income-Tax Act, 2025, if applicable.

What This Means for Shareholders

The dispatch of physical letters with web-links highlights the ongoing transition towards digital communication in corporate governance while maintaining inclusivity for shareholders who have not opted for electronic modes. For investors, ensuring their contact details are updated with depository participants is crucial to receiving timely information about dividends, meetings, and other material announcements. The availability of the Annual Report online allows immediate access to the company’s financial performance, including the Q1FY27 results which showed a 48% rise in net profit to ₹432.10 crore, providing context for the full-year outlook presented in the report.

Alkem Laboratories reported a 15% year-on-year reduction in its Scope 1 and Scope 2 greenhouse gas emissions for the financial year ended March 31, 2026, marking significant progress toward its voluntary target of a 42% cut by FY 2033 from an FY 2023 baseline. The Mumbai-based pharmaceutical company also recorded a 22% decrease in overall energy consumption, with renewable sources accounting for approximately 27% of its total energy mix during the period.

The disclosure was made under Regulation 34(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, via its Business Responsibility and Sustainability Report (BRSR) for FY26. Deloitte Haskins & Sells LLP provided reasonable assurance on the core indicators of the report. The data reflects standalone operations, noting that the generic business undertaking was transferred to Alkem Wellness Limited effective October 1, 2025.

Environmental Performance

Total Scope 1 and Scope 2 emissions declined to 93,205 tCO2e in FY26, down from 1,09,097 tCO2e in FY25. Scope 1 emissions dropped sharply to 19,088.7 metric tonnes of CO2 equivalent, compared to 33,018 metric tonnes in the previous year. Scope 2 emissions (market-based) were recorded at 74,116.3 metric tonnes of CO2 equivalent, slightly lower than the 76,079 metric tonnes reported in FY25.

Energy efficiency initiatives included the installation of IoT-enabled meters for real-time monitoring and the use of bio-briquettes in boilers as an alternative to fossil fuels. The company achieved ISO 50001 certification across 100% of its operational units. Total energy consumption was 7,54,500 GJ, comprising 2,01,332 GJ from renewable sources and 5,53,168 GJ from non-renewable sources.

Waste and Water Management

Alkem recycled 4,376 metric tonnes of plastic packaging waste under its Extended Producer Responsibility (EPR) framework in FY26, up from 3,961 metric tonnes in FY25. The company recycled or reused 99% of its non-hazardous waste. Total waste generated was 6,228 metric tonnes, of which 5,151 metric tonnes were recycled and 780 metric tonnes underwent other recovery operations.

Water stewardship remains a key priority, with the company targeting water neutrality by FY 2030. Total water withdrawal decreased to 6,19,064 kilolitres from 6,84,761 kilolitres in FY25. Approximately 84% of treated wastewater was reused within facilities for utilities and landscaping. Zero Liquid Discharge systems are operational at 58% of manufacturing units.

Social and Governance Metrics

The company maintained a Lost Time Injury Frequency Rate (LTIFR) of 0.07 per one million person-hours worked for workers, down from 0.09 in FY25. No fatalities were reported. Employee well-being spending constituted 0.2% of total revenue, down from 0.3% in the previous year. Gender diversity in the total workforce stood at 3.39%, with women comprising 17% of the Board of Directors.

What the Numbers Show

The sharp decline in Scope 1 emissions (from 33,018 to 19,088.7 tCO2e) outpaced the reduction in total energy consumption, suggesting that fuel switching—specifically the adoption of bio-briquettes and cleaner fuels—was a more potent driver of decarbonization than pure efficiency gains during FY26. This structural shift in the energy mix aligns with the company’s stated strategy to increase the share of cleaner energy sources.